Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856

被引：29

作者：

Perreault, Stephane ^{[1
]}

Chandrasekhar, Jayaraman ^{[1
]}

Cui, Zhi-Hua ^{[1
]}

Evarts, Jerry ^{[1
,3
]}

Hao, Jia ^{[2
]}

Kaplan, Joshua A. ^{[2
]}

Kashishian, Adam ^{[1
]}

Keegan, Kathleen S. ^{[1
]}

Kenney, Thomas ^{[1
]}

Koditek, David ^{[2
]}

Lad, Latesh ^{[2
]}

Lepist, Eve-Irene ^{[2
]}

McGrath, Mary E. ^{[2
]}

Patel, Leena ^{[1
]}

Phillips, Bart ^{[2
]}

Therrien, Joseph ^{[1
]}

Treiberg, Jennifer ^{[1
]}

Yahiaoui, Anella ^{[1
]}

Phillips, Gary ^{[1
]}

机构：

[1] Gilead Sci Inc, 199 E Blaine St, Seattle, WA 98102 USA

[2] Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA

[3] Acerta Pharma, 15400 SE 30th Pl,Suite 206, Bellevue, WA 98007 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2017年 / 60卷 / 04期

关键词：

SELECTIVE PI3K-BETA; BIOLOGICAL EVALUATION; RECEPTOR ANTAGONISTS; RATIONAL DESIGN; CANCER; PATHWAY; DERIVATIVES; IDELALISIB; SERIES; BIOISOSTERES;

D O I：

10.1021/acs.jmedchem.6b01821

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Phosphoinositide 3-kinase (PI3K) beta signaling is required to sustain cancer cell growth in which the tumor suppressor phosphatase and tensin homolog (PTEN) has been deactivated. This manuscript describes the discovery, optimization, and in vivo evaluation of a novel series of PI3K beta/delta inhibitors in which PI3K beta potency was built in a PI3K delta-selective template. This work led to the discovery of a highly selective PI3K beta/delta inhibitor displaying excellent pharmacokinetic profile and efficacy in a human PTEN-deficient LNCaP prostate carcinoma xenograft tumor model.

引用

页码：1555 / 1567

页数：13

共 50 条

[41] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
Huemer F.
Bartsch R.
Gnant M.
[J]. Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
[42] CoA Synthase is in complex with p85αPI3K and affects PI3K signaling pathway
Breus, Oksana
Panasyuk, Ganna
Gout, Ivan T.
Filonenko, Valeriy
Nemazanyy, Ivan
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (04) : 581 - 585
[43] Biophysical and Structural Characterization of Novel RAS-Binding Domains (RBDs) of PI3Kα and PI3Kγ
Martinez, Nicholas G.
Thieker, David F.
Carey, Leiah M.
Rasquinha, Juhi A.
Kistler, Samantha K.
Kuhlman, Brian A.
Campbell, Sharon L.
[J]. JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (08)
[44] Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
Evans, Catherine A.
Liu, Tao
Lescarbeau, Andre
Nair, Somarajan J.
Grenier, Louis
Pradeilles, Johan A.
Glenadel, Quentin
Tibbitts, Thomas
Rowley, Ann M.
DiNitto, Jonathan P.
Brophy, Erin E.
O'Hearn, Erin L.
Ali, Janid A.
Winkler, David G.
Goldstein, Stanley I.
O'Heam, Patrick
Martin, Christian M.
Hoyt, Jennifer G.
Soglia, John R.
Cheung, Culver
Pink, Melissa M.
Proctor, Jennifer L.
Palombella, Vito J.
Tremblay, Martin R.
Castro, Alfredo C.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (09): : 862 - 867
[45] The Phosphatidylinositol 3-Kinase (PI3K) Isoform Dependence of Tumor Formation Is Determined by the Genetic Mode of PI3K Pathway Activation Rather than by Tissue Type
Utermark, Tamara
Schmit, Fabienne
Lee, Sang Hyun
Gao, Xueliang
Schaffhausen, Brian S.
Roberts, Thomas M.
[J]. JOURNAL OF VIROLOGY, 2014, 88 (18) : 10673 - 10679
[46] Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection
Pillinger, Genevra
Loughran, Niamh V.
Piddock, Rachel E.
Shafat, Manar S.
Zaitseva, Lyubov
Abdul-Aziz, Amina
Lawes, Matthew J.
Bowles, Kristian M.
Rushworth, Stuart A.
[J]. ONCOTARGET, 2016, 7 (26) : 39784 - 39795
[47] Discovery of Potent and Selective PI3Kδ Inhibitors for the Treatment of Acute Myeloid Leukemia
Tang, Yongmei
Zheng, Yanan
Hu, Xueping
Zhao, Huajun
Cui, Sunliang
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6638 - 6657
[48] PI3K Inhibitors in Cardiovascular Disease
Eisenreich, Andreas
Rauch, Ursula
[J]. CARDIOVASCULAR THERAPEUTICS, 2011, 29 (01) : 29 - 36
[49] Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors
de Turiso, Felix Gonzalez-Lopez
Shin, Youngsook
Brown, Matthew
Cardozo, Mario
Chen, Yi
Fong, David
Hao, Xiaolin
He, Xiao
Henne, Kirk
Hu, Yi-Ling
Johnson, Michael G.
Kohn, Todd
Lohman, Julia
McBride, Helen J.
McGee, Lawrence R.
Medina, Julio C.
Metz, Daniela
Miner, Kent
Mohn, Deanna
Pattaropong, Vatee
Seganish, Jennifer
Simard, Jillian L.
Wannberg, Sharon
Whittington, Douglas A.
Yu, Gang
Cushing, Timothy D.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (17) : 7667 - 7685
[50] Novel inhibitors of the PI3K family
Carnero, Amancio
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (09) : 1265 - 1277

← 1 2 3 4 5 →